Mark Vander Lugt Profile | University ...

Dr. Mark Vander Lugt, MD

Claim this profile

University of Michigan Hospitals - Michigan Medicine

Studies Krabbe Disease
Studies Enzyme Disorder
6 reported clinical trials
12 drugs studied

Area of expertise

1

Krabbe Disease

Mark Vander Lugt, MD has run 3 trials for Krabbe Disease. Some of their research focus areas include:

GALC positive
psychosine positive
2

Enzyme Disorder

Mark Vander Lugt, MD has run 3 trials for Enzyme Disorder. Some of their research focus areas include:

GALC positive
psychosine positive

Affiliated Hospitals

Image of trial facility.

University Of Michigan Hospitals - Michigan Medicine

Image of trial facility.

The University Of Michigan

More about Mark Vander Lugt, MD

Clinical Trial Related

4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Mark Vander Lugt, MD has experience with

  • FBX-101
  • Fludarabine
  • Busulfan
  • Cell Processing For TCRαβ+/CD19+ Depletion
  • Bone Marrow Hematopoietic Stem Cell Transplantation
  • Cyclophosphamide

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Mark Vander Lugt, MD specialize in?

Is Mark Vander Lugt, MD currently recruiting for clinical trials?

Are there any treatments that Mark Vander Lugt, MD has studied deeply?

What is the best way to schedule an appointment with Mark Vander Lugt, MD?

What is the office address of Mark Vander Lugt, MD?

Is there any support for travel costs?